US12286406B2

Inhibitors of receptor interacting protein kinase I for the treatment of …

University of Texas System

Abstract

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Richard T. Lewis
Priority date: September 27, 2019
Filing date: July 20, 2023
Grant date: April 29, 2025
Publication date: April 29, 2025
Language: en
PDF source: https://patentimages.storage.googleapis.com/5b/10/41/c4cee1327edee6/US12286406B2.pdf
Metadata fetched: August 29, 2026 00:33